Bill has extensive experience representing placement agents and underwriters in structuring and executing initial public offerings, alternative public offerings, including reverse mergers, Form 10/Resale S-1 club deals and confidentially marketed IPOs, Confidentially Marketed Public Offerings (CMPOs), registered directs, PIPEs and private placements. Bill represents venture capital firms and private equity firms in customized investments in public companies, including structured PIPEs and registered directs, in OTC and exchange listed companies. Bill also represents public companies in public and private financings, SEC compliance, corporate governance, and general counseling.
Bill has extensive experience representing buyers and sellers in M&A transactions, including public company deals, private company deals, and spin-offs. Bill regularly represents domestic and foreign companies, and he is well-versed in issues specific to cross-border deals.
Additionally, Bill represents private companies and investors in venture capital transactions.
Bill has extensive experience representing placement agents and underwriters in structuring and executing initial public offerings, alternative public offerings, including reverse mergers, Form 10/Resale S-1 club deals and confidentially marketed IPOs, Confidentially Marketed Public Offerings (CMPOs), registered directs, PIPEs and private placements. Bill represents venture capital firms and private equity firms in customized investments in public companies, including structured PIPEs and registered directs, in OTC and exchange listed companies. Bill also represents public companies in public and private financings, SEC compliance, corporate governance, and general counseling.
Bill has extensive experience representing buyers and sellers in M&A transactions, including public company deals, private company deals, and spin-offs. Bill regularly represents domestic and foreign companies, and he is well-versed in issues specific to cross-border deals.
Additionally, Bill represents private companies and investors in venture capital transactions.
Publications
-
Co-author,
Unblocking Clogged PIPEs: SEC Focuses on Availability of Rule 415, Insights ()
Speaking Engagements
-
Moderator,
Private Financing: When to Raise Money and from Whom?,
Boston Biotech CEO Conference,
Boston, MA
-
Speaker,
The Buyside Perspective: Which Sectors are Hot, Which Sectors are Not?,
The Boston Biotech Business Development Conference,
Boston, MA
-
Moderator,
The Road Less Traveled: Alternative Avenues to Public Markets,
BIO CEO & Investor Conference,
Biotechnology Industry Organization - BIO, New York, NY
-
Speaker,
JOBS Act Part II: What Role May Revised Rule 506 Offerings and Crowdfunding Play in Biotech?,
BioWorld, Webinar
-
Speaker,
How Life Sciences Firms Can Leverage the JOBS Act to Go Public by Traditional and Alternative Paths,
BioWorld, Webinar
-
Moderator,
Crowd Funding and Internet-based Private Placements,
Com.vention NY, New York, NY
-
Panelist,
The American JOBS Act: What Does It Really Mean for the Biotech Industry?,
New York Biotechnology Association 21st Annual Meeting,
NYBA, New York, NY
-
Panelist,
Social Networking Technologies and Their Integration with Crowdfunding Websites,
Crowdfunding Conference,
DealFlow Media, New York, NY
-
Speaker,
Creative Structures for Getting Deals Done in a Challenging Environment,
PIPEs Conference 2011,
DealFlow Media, New York, NY
-
Panelist,
Current Developments in Private Placements and PIPEs,
Securities Regulation Committee,
Securities Regulation Committee, Saratoga Springs, NY
-
Speaker,
Trends in PIPEs, Registered Directs, CMPOs, and Bought Deals,
Securities Section,
Boston Bar Association, Boston, MA
Newsroom
-
Mintz Levin’s William C. Hicks to Moderate Panel at 2013 BIO CEO and Investor Conference, ()
-
Quoted in
SEC Looks to Expand Yet-to-Be-Implemented JOBS Provisions, BioWorld ()
-
Quoted in
Financings of the Fortnight Says It’s Not Ova Til It's Ova, The InVivo Blog ()
-
Quoted in
Biotechs Opt for Alternative Flotation Strategy, Nature Biotechnology ()
-
Quoted in
SEC Approves Proposed Rule for JOBS Act Reg D Change, BioWorld Today ()
-
Quoted in
IPO Line Starting to Form behind the JOBS Act, BioWorld Insights ()
-
Mintz Levin Represents Underwriters Jefferies & Company and Leerink Swann, LLC in $20 Million Public Offering of Unilife Corporation, ()
-
Quoted in
NASDAQ Rejects Structure to Skirt 20% Rule, Attorneys Say, PIPEs Report ()
-
Quoted in
What JOBS Means for Biotech: More Money, Less Regulation, BioWorld Today ()
-
Quoted in
Opportunity vs. Vulnerability in New Fundraising Initiatives, BioWorld Insight ()
-
Quoted in
Crowd-Funding is Coming, But Will it Be Niche Only?, BioWorld Insight ()
-
Quoted in
Creating an IPO Alternative for Small Biotechs, BioWorld Insight ()
-
Quoted in
Reg-A, Crowd-Funding Bills Expand Options for Biotechs, BioWorld Today ()
-
Mintz Levin Expands Corporate & Securities Section with Addition of William C. Hicks, ()
-
Quote in
SEC Clarifies Rule 415, Attorneys Say, PIPEs Report ()
-
Quoted in
Gresham’s Got Talent with All-cash Agency Deal, Financial News Online ()
-
Quoted in
Lacking Leverage, Firms Embrace EBOs, Wall Street Journal ()